Lignée cellulaire de myèlomes transformée et procédé d'expression d'un gène codant un polypéptide eucaryotique employant cette lignée

History

What the Federal Institute of Intellectual Property published about this title, newest first.

1. Apr 28, 2006

   Maximum term reached

   Published in +pat+ No 8 in 2006

2. Sep 14, 2001

   Address changed

   Owner

   Alusuisse Holdings A.G., Badische Bahnhofstrasse 16, 8212 Neuhausen am Rheinfall → Alusuisse Lonza Group AG, Feldeggstrasse 4, 8034 Zürich

   Published in PIDTJ No 17 in 2001

3. Sep 14, 2001

   Transferred

   Owner

   Alusuisse Lonza Group AG, Feldeggstrasse 4, 8034 Zürich → Lonza Group AG, Feldeggstrasse 4, 8034 Zürich

   Published in PIDTJ No 17 in 2001

4. May 29, 1998

   Address changed

   Owner

   Celltech Limited, 244-250 Bath Road, Slough/Berks, United Kingdom → CELLTECH THERAPEUTICS LIMITED, 216 Bath Road, Slough,, Berkshire SL1 4EN, United Kingdom

   Published in PIDTJ No 10 in 1998

5. May 29, 1998

   Transferred

   Owner

   CELLTECH THERAPEUTICS LIMITED, 216 Bath Road, Slough,, Berkshire SL1 4EN, United Kingdom → Alusuisse Holdings A.G., Badische Bahnhofstrasse 16, 8212 Neuhausen am Rheinfall

   Published in PIDTJ No 10 in 1998

6. May 29, 1998

   Agent entered

   Representative

   Andrew Kerr, Patentanwalt, Finkelerweg 44, Postfach, 4144 Arlesheim → Braun & Partner, Patent-, Marken-, Rechtsanwälte, Reussstrasse 22, CH-4054 Basel

   Published in PIDTJ No 10 in 1998

7. Feb 28, 1990

   Granted

   Published in PIDTJ No 4 in 1990

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.